The Microbiome Drug Landscape report: Promising clinical performance and signs of a maturing industry

In a year dominated by the COVID-19 pandemic, industry-leading microbiome-based drug products show strong clinical performance as established companies successfully garner new funds

This content is password protected. To view it please enter your password below:

Luis Gosálbez
Managing Director at

Sandwalk BioVentures is a specialty strategy, innovation, regulatory and management consulting firm focused on microbiome technologies servicing companies in the food and pharma sectors, as well as financial and strategic investors exploring to enter this field. The company has created the Microbiome Drug Database™, an online repository containing the most extensive and thorough analysis of biotechnology companies developing pharmaceuticals from or through the microbiome.